Navigation Links
InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
Date:12/3/2008

Cellastim, an animal-free recombinant albumin product manufactured by InVitria, can outperform animal and human derived serum in CHO cell culture.

Fort Collins, CO (PRWEB) December 3, 2008 -- Cellastim has proven to be a robust replacement for serum derived albumin in CHO media and can improve both the growth kinetics and productivity of CHO cell lines across a variety of chemically defined media.

Studies support InVitria's claim that its Cellastim Cellastim outperforms other chemically defined cell culture ingredients and can be used by the biopharmaceutical, mammalian cell culture, stem cell and regenerative medicine industries as a supplement for cell culture media.

Cellastim is a defined supplement that can enhance performance of chemically defined media. One study revealed that Cellastim outperformed plasma-derived human serum albumin with a 50% average increase in productivity in several chemically defined cell culture media.

"InVitria's Cellastim helps optimize cell culture media performance safely and effectively," said InVitria President Scott Deeter. "As a regulatory friendly product, Cellastim can provide researchers an option to free their cells from the risk of potentially harmful contaminants, while simultaneously enhancing cell growth and productivity."

The conversion from serum supplemented media to serum-free media for production of biopharmaceuticals in CHO cells is essential for the elimination of all animal components in the culturing media. The addition of InVitria's Cellastim offers optimal defined quality and safety for the production of biopharmaceuticals in CHO cells.

About InVitria:
InVitria has developed defined and animal-free cell culture media components that enhance cell growth, productivity, safety and time to market for companies in the biopharmaceutical, mammalian cell culture, regenerative medicine, cell therapy, stem cell and diagnostics industry. Cellastim is an animal free component used to enhance cell growth and productivity in cell culture media.

For more information about InVitria's products or to place an order, please contact InVitria's sales and marketing team by e-mail or phone.

E-mail: info (at) InVitria.com         
Phone: 1-800-916-8311

###

Read the full story at http://www.prweb.com/releases/CHOCellCulture/Cellastim/prweb1702944.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Internet Service Delivers Relief to Families of Those in Long-Term Care
2. New Software Streamlines Interface Management, Delivers More System Security and Greater IT Control
3. Healthplace America Delivers the First and Only Surgery Benefit Management Solution Through the Healthplace Benefit(TM)
4. Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008.
5. Decision Intelligence Delivers Marketing Contact Optimization Solutions
6. Illinois Commerce Commission Delivers $207 Million Ameren Rate Hike
7. Pennsylvania Commission for Women Delivers First Womens Wellness Guide Kiosk to Allegheny County Jail
8. SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients
9. Specialty Renal Pharmacy Delivers One Millionth Prescription
10. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
11. New Website Portal Delivers Pre-Qualified Spinal Decompression Patients to Participating Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... New Jersey (PRWEB) , ... February 27, 2017 , ... ... highest cancer rates, among all types and genders. And the need for advanced services ... by RWJ and its top-rated cancer care program, in collaboration with their non-profit partners ...
(Date:2/26/2017)... ... February 26, 2017 , ... Today, A' Design Awards ... of International Social Design Awards. , The 7th A' Social Design Award ... and Institutions worldwide with realized projects and conceptual works. , The first phase ...
(Date:2/26/2017)... , ... February 26, 2017 , ... NuevaCare, a leading ... diverse as Millbrae, Belmont, and Palo Alto, is proud to announce an important upgrade ... Area consumers look for home care close to home, and by having city-specific pages, ...
(Date:2/26/2017)... ... ... IndustryArchive.Org . is announcing a new way for B2B Sellers to ... pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase a ... that B2B buyers are controlling the sales process via the Internet and that ad ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today it will exhibit ... Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, ... to improve Medicaid population health management. , ODH will also have an exhibit booth ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017  International Biophysics Corporation, a ... , today announced a 34% revenue growth in 2016 ... increase in unit sales.  This growth was fueled by its ... in addition to the expansion of its global sales of ... International Biophysics, CEO, "As we enter our 25 th ...
(Date:2/27/2017)... ROCKVILLE, Md. , Feb. 27, 2017 /PRNewswire/ ... "RegeneRx"), a clinical-stage drug development company focused on ... its licensee for RGN-137, GtreeBNT Co., Ltd., received ... its Phase 3 clinical trial design for RGN-137 ... dermal wound healing gel that incorporates Thymosin beta ...
(Date:2/27/2017)... 27, 2017 Leading Countries, Technologies and Companies ... expected to grow at a CAGR of 8.9% from 2016-2021 and ... at a CAGR of 9.1% from 2016 to 2027. The market ... ... benefit you Read on to discover how you can exploit ...
Breaking Medicine Technology: